NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kind Pharmaceutical

Kind Pharmaceutical

Private
HangzhouHealthcare & Life Scienceshttps://www.kindpharmaceutical.com/

Last Round

Series C

Nov 12, 2025

Total Funding Raised

$141.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kind Pharmaceutical is a biopharmaceutical company that develops innovative medicines for the treatment of hematological diseases and cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologydrug discoveryclinical trialsbreast cancer treatmentselective estrogen receptor covalent antagonistSERCAbiotechdrug developmentclinical-stage biotechER+ breast cancertherapeutic developmentpharma R&Dlicensing agreementsmall molecule drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kind Pharmaceutical Comps

Public and private peers based on sector, stage, and business model.

Kind Pharmaceutical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kind Pharmaceutical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 12, 2025

Kind Pharmaceutical Investors

Notable investors and investment history

Kind Pharmaceutical investors
InvestorRounds
Northern Light Venture CapitalSeries C, Series B
C&D Emerging Industry Equity InvestmentSeries C
Efung CapitalSeries B, Series C
Decheng CapitalSeries B, Series A
Taiping Fund Management Co., Ltd.Series C
Gaorong CapitalSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    $57M round led by C&D Emerging Industry Equity Investment and Taiping Fund Management.

Kind Pharmaceutical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kind Pharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kind Pharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2014
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.